Organization
Aimmune Therapeutics
2 clinical trials
Clinical trial
A Multicenter, Open-Label, Longer-Term Study of AR101 Characterized Oral Desensitization Immunotherapy in Subjects Who Participated in a Prior AR101 StudyStatus: Completed, Estimated PCD: 2023-04-27
Clinical trial
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)Status: Completed, Estimated PCD: 2022-07-05